Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

August
23
2019

SRT is a Great Alternative for Treating Non Melanoma Skin Cancer vs using Mohs Surgery

NMSC includes Basal Cell Carcinoma and Squamous Cell Carcinoma. These cancers are rarely life-threatening but can cause complications if they are left untreated. Many dermatologists default to Mohs Surgery for the treatment of these malignancies….

August
08
2019

Sensus Healthcare Reports Second Quarter 2019 Financial Results

· Resumes double-digit revenue growth, up 23% over the prior year quarter · Affirms expectations for full-year double-digit revenue growth · Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 08,…

July
30
2019

Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019

BOCA RATON, Fla., July 30, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

July
23
2019

SRT & Keloid Treatment: Tony Perkins Interview

We had the pleasure of inviting patient advocate Tony Perkins to the Sensus Headquarters to tell his story of how utilizing superficial radiation therapy (SRT) as his post-operative keloid treatment help changed his life. Throughout…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry